JP2018519356A5 - - Google Patents

Info

Publication number

JP2018519356A5

JP2018519356A5 JP2018506815A JP2018506815A JP2018519356A5 JP 2018519356 A5 JP2018519356 A5 JP 2018519356A5 JP 2018506815 A JP2018506815 A JP 2018506815A JP 2018506815 A JP2018506815 A JP 2018506815A JP 2018519356 A5 JP2018519356 A5 JP 2018519356A5

Authority

JP

Japan

Prior art keywords

item

domain

car

genetically modified

kma

Prior art date

2016-04-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 52
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 33
• 108700013903 SANT-7 Proteins 0.000 claims description 20
• 239000000427 antigen Substances 0.000 claims description 18
• 102000036639 antigens Human genes 0.000 claims description 18
• 108091007433 antigens Proteins 0.000 claims description 18
• 239000003550 marker Substances 0.000 claims description 18
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims description 17
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims description 17
• 230000000139 costimulatory effect Effects 0.000 claims description 17
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 14
• 230000004068 intracellular signaling Effects 0.000 claims description 14
• 125000006850 spacer group Chemical group 0.000 claims description 12
• 239000013543 active substance Substances 0.000 claims description 10
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 9
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 7
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 7
• 201000011510 cancer Diseases 0.000 claims description 7
• 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims description 6
• 206010028980 Neoplasm Diseases 0.000 claims description 6
• 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims description 6
• 230000036210 malignancy Effects 0.000 claims description 6
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
• 239000012634 fragment Substances 0.000 claims description 4
• 239000003276 histone deacetylase inhibitor Substances 0.000 claims description 4
• 229940121372 histone deacetylase inhibitor Drugs 0.000 claims description 4
• 208000034578 Multiple myelomas Diseases 0.000 claims description 3
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims description 3
• 206010002022 amyloidosis Diseases 0.000 claims description 3
• 239000002246 antineoplastic agent Substances 0.000 claims description 3
• 229940127089 cytotoxic agent Drugs 0.000 claims description 3
• 239000002955 immunomodulating agent Substances 0.000 claims description 3
• 229940121354 immunomodulator Drugs 0.000 claims description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 3
• 101100228196 Caenorhabditis elegans gly-4 gene Proteins 0.000 claims 2
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical group NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 claims 2
• 239000004471 Glycine Substances 0.000 claims 2
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 2
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
• 239000003814 drug Substances 0.000 claims 2
• 102000023732 binding proteins Human genes 0.000 claims 1
• 108091008324 binding proteins Proteins 0.000 claims 1
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
• 230000031146 intracellular signal transduction Effects 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 238000000034 method Methods 0.000 description 88
• 108091026890 Coding region Proteins 0.000 description 11
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 7
• 229940125754 MDX-1097 Drugs 0.000 description 7
• 210000003705 ribosome Anatomy 0.000 description 7
• 102100026019 Interleukin-6 Human genes 0.000 description 5
• 238000011476 stem cell transplantation Methods 0.000 description 5
• 239000013604 expression vector Substances 0.000 description 4
• 229920001184 polypeptide Polymers 0.000 description 4
• 102000004196 processed proteins & peptides Human genes 0.000 description 4
• 108090000765 processed proteins & peptides Proteins 0.000 description 4
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• 239000000833 heterodimer Substances 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 2
• NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 2
• 230000000735 allogeneic effect Effects 0.000 description 2
• BWDQBBCUWLSASG-MDZDMXLPSA-N (e)-n-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1h-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide Chemical compound C=1NC2=CC=CC=C2C=1CCN(CCO)CC1=CC=C(\C=C\C(=O)NO)C=C1 BWDQBBCUWLSASG-MDZDMXLPSA-N 0.000 description 1
• OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
• 108010002156 Depsipeptides Proteins 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
• RTKIYFITIVXBLE-UHFFFAOYSA-N Trichostatin A Natural products ONC(=O)C=CC(C)=CC(C)C(=O)C1=CC=C(N(C)C)C=C1 RTKIYFITIVXBLE-UHFFFAOYSA-N 0.000 description 1
• 229910052768 actinide Inorganic materials 0.000 description 1
• 150000001255 actinides Chemical group 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• INVTYAOGFAGBOE-UHFFFAOYSA-N entinostat Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC(=O)OCC1=CC=CN=C1 INVTYAOGFAGBOE-UHFFFAOYSA-N 0.000 description 1
• 229950005837 entinostat Drugs 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 229960004942 lenalidomide Drugs 0.000 description 1
• GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 description 1
• FWZRWHZDXBDTFK-ZHACJKMWSA-N panobinostat Chemical group CC1=NC2=CC=C[CH]C2=C1CCNCC1=CC=C(\C=C\C(=O)NO)C=C1 FWZRWHZDXBDTFK-ZHACJKMWSA-N 0.000 description 1
• 229960005184 panobinostat Drugs 0.000 description 1
• 239000002464 receptor antagonist Substances 0.000 description 1
• 229940044551 receptor antagonist Drugs 0.000 description 1
• OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 description 1
• 229960003433 thalidomide Drugs 0.000 description 1
• 230000017105 transposition Effects 0.000 description 1
• RTKIYFITIVXBLE-QEQCGCAPSA-N trichostatin A Chemical compound ONC(=O)/C=C/C(/C)=C/[C@@H](C)C(=O)C1=CC=C(N(C)C)C=C1 RTKIYFITIVXBLE-QEQCGCAPSA-N 0.000 description 1
• 229960000604 valproic acid Drugs 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 description 1
• 229960000237 vorinostat Drugs 0.000 description 1